RA 7719, officially titled the “National Blood Services Act of 1994,” enacted to overhaul the former Blood Bank Act (RA 1517, 1956)
Passed through Senate Bill No. 1011 and House Bill No. 879 during the 9th Congress.
Signed into law: ext{April 28, 1994}
Approved by President Fidel V. Ramos: ext{May 15, 1994}
Published in the Official Gazette: ext{Aug 18, 1994}
Effectivity date: ext{Aug 23, 1994} (15 days after publication).
Implementing Rules & Regulations (IRR) released via DOH Administrative Order No. 9, Series of 1995 on ext{Apr 28, 1995} (10 chapters, 50 sections).
Supreme-Court-upheld case: Rodolfo S. Beltran v. DOH Secretary – owners of commercial blood banks challenged the phase-out clause; the Court sustained DOH, reaffirming public-health primacy.
1979 – AIDS first described; global alarm on blood safety.
1982 – First transfusion-associated AIDS case (infant).
1984 – First Philippine HIV infection recorded.
1985 – ISBT guideline: mandatory AIDS testing for donor blood.
1989 – DOH AO 57-s-1989: updated blood-bank guidelines; required Hep B & HIV tests; mandated pathologist/hematologist supervision.
1992 – DOH AO 118-A-s-1992: created National Blood Services Program (NBSP) – focus on adequate, equitable, safe blood.
Data on 1992 collections:
64.4\% – commercial blood banks.
14.5\% – Philippine National Red Cross (PNRC).
13.7\% – government hospital-based banks.
7.4\% – private hospital-based banks.
Only 24 licensed commercial blood banks, yet each produced:
\approx 5\times more units than PNRC.
\approx 15\times more than government-run banks.
Paid-donor prevalence:
99.6\% of commercial-bank donors remunerated.
77.0\% of private hospital-bank donors remunerated.
Infection risk: blood bought from paid donors \approx 3\times more likely to carry malaria, syphilis, Hep B, or HIV.
Promote voluntary donation; view donation as humanitarian.
Blood transfusion = professional medical service, not commodity sale.
Provide adequate, safe, affordable, equitable blood supply.
Public education to curb hazards of commercial sale.
Integrate voluntary-donation principles in formal & non-formal curricula.
Mobilize multi-sector community participation.
Mandate DOH to build a National Blood Transfusion Service Network.
Financial assistance/reimbursement for non-profit blood services.
Require all collection units & banks to be non-profit.
Establish scientific standards & regulate all collection/storage activities.
Upgrade banks to include preventive services & TTI-control education.
Total sections: 15.
Mandatory phase-out of all commercial blood banks within 2 years of effectivity (target: Aug 23, 1996).
Explicit repeal of RA 1517.
Blood – human blood for transfusion.
Blood products / components – therapeutic derivatives (whole blood, packed RBC, granulocytes, plasma, platelets, cryoprecipitate, cryosupernate, etc.).
Fresh Whole Blood (FWB) – collected within 24 h; becomes Whole Blood (WB) after 48 h.
Packed Red Blood Cells (PRC) – plasma-reduced via gravity or centrifugation (+2^\circ\text{C} to +6^\circ\text{C}).
Washed RBC – saline-washed to remove proteins/antibodies/electrolytes.
Granulocyte concentrate – via apheresis.
Leukocyte-depleted RBC – passed through 3rd-generation filter.
Platelet concentrate (random donor) – prepared within 8 h; stored +20^\circ\text{C}–+24^\circ\text{C} with agitation.
Cryoprecipitate – cold-insoluble fraction; prepared by thawing FFP 1^\circ–6^\circ\text{C} then refreezing within 1 h.
Cryosupernate – plasma left after cryoprecipitate removal; contains most clotting factors.
Fresh Frozen Plasma (FFP) – frozen within 6–8 h; stored \le -30^\circ\text{C}.
Government-owned – national, LGU, or any public subdivision/agency.
Private-owned – individual, corporation, association, organization.
Hospital-based – within hospital premises.
Non-hospital-based – stand-alone; may be government or PNRC.
Blood Station (BS)
Voluntary-donation promotion; storage, issuance, transport of whole blood/PRC.
Compatibility testing (if hospital-based).
Blood Collection Unit (BCU)
Advocacy; donor recruitment/selection/counselling.
Mobile or in-house collection; transports blood to Blood Center for testing.
BS/BCU (Hybrid) – performs all BS and BCU functions.
Blood Bank (BB)
Advocacy plus storage/issuance of whole blood/components.
Performs compatibility testing, Direct Coombs, antibody screen, transfusion-reaction investigation, hemovigilance.
Blood Center (BC)
Full spectrum: donor management, collection, TTI testing, component processing, storage, distribution.
Mandatory tests in BCs only:
HIV 1/2 antibody,
Hepatitis B surface antigen (HBsAg),
Hepatitis C antibody (anti-HCV),
Malaria,
Syphilis.
End-user hospitals must not retest; issuing BC bears responsibility for negativity certification.
Under RA 11166 (2018), recipients may request a second HIV test.
Hospital-based BS: headed by Board-certified pathologist; if unavailable, the hospital’s clinical-laboratory physician after ≥3-month blood-bank training.
Non-hospital BS: physician with ≥3 months formal basic-blood-bank training.
Non-hospital BCU/BC/BS-BCU: physician with DOH-recognized formal training.
BCs & Blood Banks: pathologist (Philippine Board of Pathology) or hematologist (Philippine Board of Hematology) with BSF experience.
Authority to Operate (ATO) – permit for BCU or BS.
License to Operate (LTO) – permit for Blood Banks or Blood Centers.
Application filed with DOH – Health Facilities & Services Regulatory Bureau (HFSRB) or corresponding Center for Health Development (CHD).
Inspection timeline:
CHD inspects within 30 days of application.
Post-inspection: approve & release ATO/LTO within 15 days or disapprove with written findings.
If unacted after 30 days → deemed approved (automatic approval clause).
Validity:
Stand-alone BSF ATO/LTO – 3 years.
If integrated into a hospital license – 1 year.
Non-transferable; new application needed for change of location.
Emergencies: unlicensed hospitals may collect/transfuse under attending physician’s responsibility, subject to DOH conditions.
HFSRB & CHD directors/representatives may conduct regular on-site visits; full access to records.
Absence of ATO/LTO → immediate closure; agencies may enlist police/other authorities.
Administrative penalties (reprimand, suspension, revocation) for:
a. Material falsehoods in application.
b. Misrepresentation/falsification of records.
c. Denial of record access to inspectors.
d. Charging fees above DOH-set maximum.
e. Collecting blood from paid/remunerated donors.
f. Refusal to participate in External Quality Assessment Scheme (EQAS).
Appeals: aggrieved parties may elevate CHD decisions to DOH Secretary within 30 days; Secretary’s ruling is final & executory.
Criminal offenses (after notice & hearing):
a. Collecting charges above DOH ceiling → possible license suspension/revocation.
b. Operating a blood bank without LTO or failing DOH standards.
c. Heads/personnel dispensing or transfusing blood proven contaminated with TTI & not disposing within 48 h.
Weight: ≥ 110\;\text{lb} (≈ 50\;\text{kg}) → dictates collection volume.
Pulse: 60–100\;\text{bpm}, regular.
Blood Pressure: 90–160\;\text{mmHg} systolic / 60–100\;\text{mmHg} diastolic.
Hemoglobin: ≥ 125\;\text{g/L} (≈ 12.5\;\text{g/dL}).
Frames blood as altruistic resource, combating commodification.
Strengthens constitutional right to health (Art. II Sec. 15, 1987 Constitution) → State obligation to make transfusion safe.
Educational insertion cultivates long-term voluntary donor culture.
Phasing out commercial banks reduces paid-donor model, thus lowering TTIs, ensuring equitable access, and harmonising with WHO advocacy for 100 % voluntary, non-remunerated donation.
Bioethics: aligns with principles of beneficence (promoting welfare of recipients) and justice (fair distribution without financial coercion).
Public-health law: similar regulatory rationales in Food & Drug, Pharmacy, HIV/AIDS statutes (RA 11166) – surveillance, licensing, and penalty structures.
Case-law illustration: Beltran v. DOH underscores police-power supremacy over proprietary interests when public health is at stake.
Strict adherence to non-profit operations and full documentation; expect unannounced inspections.
Mandatory participation in EQAS to maintain licensure and quality.
Ensure donor qualification per physiologic criteria; deviations expose facility to sanctions.
End-user hospitals must trust BC screening—repeat testing barred (except patient-initiated HIV re-test under RA 11166).
• 2\ \text{Apr 1994} – RA 7719 enacted by Congress.
• 28\ \text{Apr 1994} – Final legislative approval.
• 15\ \text{May 1994} – Presidential signing.
• 18\ \text{Aug 1994} – Publication.
• 23\ \text{Aug 1994} – Effectivity (start of 2-year commercial-bank phase-out countdown).
• 28\ \text{Apr 1995} – DOH issues IRR (AO 9-s-1995).
"VANS FACES" for Section 2 policy clauses:
V – Voluntary donation
A – Adequate & Affordable supply
N – Network (National Blood Transfusion Service Network)
S – Scientific standards / Safety regulation
F – Formal education integration
A – Assistance to non-profits
C – Community mobilisation
E – Equitable distribution
S – Services are not sales (blood ≠ commodity)
Recall 5 TTIs via “H^2 MS” (HIV, Hep B, Hep C, Malaria, Syphilis).
Administrative vs criminal penalties: link “Paper lies & price gouge” (false statements, over-charging) to admin; “No license + dirty blood” to criminal.